{"id":"bencycloquidium-bromide-nasal-spray","safety":{"commonSideEffects":[{"rate":null,"effect":"Nasal dryness"},{"rate":null,"effect":"Epistaxis"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Pharyngeal irritation"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a quaternary ammonium anticholinergic compound, bencycloquidium bromide antagonizes M3 muscarinic receptors on nasal mucosa, decreasing mucus production and secretion. When delivered as a nasal spray, it provides local anticholinergic effects to alleviate rhinorrhea and nasal congestion associated with allergic rhinitis and other nasal conditions.","oneSentence":"Bencycloquidium bromide is an anticholinergic agent that blocks muscarinic acetylcholine receptors to reduce nasal secretions and congestion.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:28:20.089Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Allergic rhinitis with rhinorrhea"},{"name":"Vasomotor rhinitis"}]},"trialDetails":[{"nctId":"NCT05038202","phase":"PHASE4","title":"Study of Bencycloquidium Bromide Nasal Spray in the Treatment of Moderate-severe Persistent Allergic Rhinitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yingu Pharmaceutical Co., Ltd","startDate":"2021-06-16","conditions":"Allergic Rhinitis","enrollment":450}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["BILITING"],"phase":"marketed","status":"active","brandName":"Bencycloquidium Bromide Nasal Spray","genericName":"Bencycloquidium Bromide Nasal Spray","companyName":"Yingu Pharmaceutical Co., Ltd","companyId":"yingu-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Bencycloquidium bromide is an anticholinergic agent that blocks muscarinic acetylcholine receptors to reduce nasal secretions and congestion. Used for Allergic rhinitis with rhinorrhea, Vasomotor rhinitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}